Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Active Comparator

Research Leaders

10 sponsors active, led by Samsung Medical Center

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT01982916Phase 3Completed

Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

Showing all 1 trials

Research Network

Common Treatments

  • Active Comparator1
  • Placebo For Agr Tablet Andor Active Comparator1
  • Agr Tablet1

Active Sponsors

  • Samsung Medical Center1
  • Seoul National University Bundang Hospital1
  • Ahn-Gook Pharmaceuticals Co.,Ltd1
  • Inha University Hospital1
  • Seoul National University Hospital1

Top Investigators

Related Conditions

  • Allergic Rhinitis1
  • Perennial Allergic Rhinitis1

Activity Timeline